Pharyngitis Therapeutics Market 2021 Is Rapidly Increasing Worldwide In Near Future By Top Companies: Genentech, Adamas Pharmaceutical, PLIVA HRVATSKA D.O.O., Pfizer
The Pharyngitis Therapeutics Market analysis report speaks about the growth rate till 2027 manufacturing process, Growth, key factors driving this market with sales, revenue, and price analysis of lead manufacturers, distributors, traders and dealers of Pharyngitis Therapeutics.
Coherent Market Insights always aims at offering their clients an in-depth analysis and the best research material of the various market. The “Pharyngitis Therapeutics Market projected to develop with growing expansion prospects”. The Pharyngitis Therapeutics Market report presents a calculated opinion of the analyzed Pharyngitis Therapeutics Market data. It explains various opportunities dedicated to different industries, suppliers, organizations, and associations offering various products and services such as offering them precise guidance for their expansion in the competition for reliable services to consumers. The report provides detailed information on key competitors in the market and on emerging companies with significant market share based on demand, revenue, sales, high-quality product manufacturers, and service providers.
The prominent players in the Pharyngitis Therapeutics Market are Genentech Inc., Adamas Pharmaceutical Inc., PLIVA HRVATSKA d.o.o., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Mylan N.V., GSK group of companies, Teva Pharmaceutical Industries Ltd., and AbbVie Inc.
Pharyngitis, also known as sore throat, is a condition where there is swelling in the back of the throat (pharynx) between the tonsils and the voice box (larynx). Pharyngitis is majorly caused by bacterial or viral infections and incidence of pharyngitis is significantly high in colder months of the year. Major causes of pharyngitis include measles, chickenpox, croup, whooping cough adenovirus, and group A streptococcus. Pharyngitis is also caused by common cold, influenza, and mononucleosis viral infections. Moreover, according to the Centers for Disease Control and Prevention (CDC), amoxicillin and penicillin are the most commonly prescribed treatments for sore throat.
Pharyngitis treatment relies on the symptoms, and on the cause of pharyngitis for example bacterial, fungal, and herpes simplex infections. Sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever are some of the common symptoms that are observed in patients suffering from pharyngitis. In some cases, strep throat condition is also observed, which results in difficulty while swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are commonly used to lessen the pain associated with pharyngitis. Moreover, aspirin is also used by adults for treating pharyngitis, however, it is not recommended for children, owing to risk of occurrence of Reye syndrome.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/2001
Furthermore, dexamethasone, a steroid, is also utilized in the treatment of pharyngitis. If pharyngitis is caused by bacterial infection, then these steroids are taken along with antibiotics. If pharyngitis is virus related, then antibiotics shows no positive results. Additionally, oral analgesic solutions are also prescribed with active ingredient phenol, as a medication for pharyngitis. Thus, availability of wide range of options available for the treatment of pharyngitis, is expected to drive growth of the pharyngitis therapeutics market over the forecast period.
According to the study by Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts published in 2016, doctors often prescribe the wrong antibiotics, and this estimates that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious lack of new antibiotics in development, underscoring that antibiotic resistance is a global health emergency set to undermine the decades of progress in modern medicine.
Therefore, market players are increasingly focusing on research and development activities for discovery of novel antibiotics or any other therapeutic drugs for the treatment of pharyngitis. For instance, Innovative Med Concepts, Inc. is in the process of developing a promising treatment for pharyngitis i.e. the company’s second novel product NRP-1, a proprietary throat spray is developed to treat viral pharyngitis, which is expected to cater to the large unmet medical needs and cause of most cases of pharyngitis. NRP-1 will also provide the required relief for cancer patients undergoing head and neck radiation plagued with disabling oral mucositis/pharyngitis. This spray delivers medication, which then adheres to the posterior pharynx despite repeated swallows and saliva.
Among regions, North America accounted for the largest share in the global pharyngitis therapeutics market in 2016, followed by Europe market. The growth in the North America market is attributed to rising prevalence of pharyngitis in North America. For instance, according to data published in the American Family Physician Journal in 2009, each year in the U.S., pharyngitis is reported to be diagnosed in 11 million people in outpatient settings.
Furthermore, Asia Pacific is also expected to witness growth during the forecast period, owing to several pharmaceutical and biotechnological companies focusing on expanding to Asia Pacific region to maximize their R&D efforts, as Asia Pacific region provides low capital investment in research and development due to lower operational cost and highly efficient technicians. Moreover, increasing government investments in research and development is also expected to fuel growth of the pharyngitis therapeutics market in Asia Pacific over the forecast period. As group A Streptococcus is the most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living conditions. The above mentioned factors are expected to provide lucrative growth opportunities drug manufacturers in Asia Pacific pharyngitis therapeutics market.
Main points in Pharyngitis Therapeutics Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Pharyngitis Therapeutics Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Pharyngitis Therapeutics Industry Impact
Chapter 2 Global Pharyngitis Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pharyngitis Therapeutics (Volume and Value) by Type
2.3 Global Pharyngitis Therapeutics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Pharyngitis Therapeutics Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Pharyngitis Therapeutics Market Analysis
Chapter 6 East Asia Pharyngitis Therapeutics Market Analysis
Chapter 7 Europe Pharyngitis Therapeutics Market Analysis
Chapter 8 South Asia Pharyngitis Therapeutics Market Analysis
Chapter 9 Southeast Asia Pharyngitis Therapeutics Market Analysis
Chapter 10 Middle East Pharyngitis Therapeutics Market Analysis
Chapter 11 Africa Pharyngitis Therapeutics Market Analysis
Chapter 12 Oceania Pharyngitis Therapeutics Market Analysis
Chapter 13 South America Pharyngitis Therapeutics Market Analysis
Chapter 14 Company Profiles and Key Figures in Pharyngitis Therapeutics Business
Chapter 15 Global Pharyngitis Therapeutics Market Forecast (2021-2027)
Chapter 16 Conclusions
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
